Perspective Therapeutics (CATX) Other financing activities (2010 - 2026)

Perspective Therapeutics (CATX) has 15 years of Other financing activities data on file, last reported at $290000.0 in Q1 2026.

• For the quarter ending Q1 2026, Other financing activities changed N/A year-over-year to $290000.0; the trailing twelve-month figure through Mar 2026 stood at $290000.0 (down 74.27% YoY), and the FY2024 full-year result was $1.3 million, changed N/A from the prior year.
• Other financing activities rose to $290000.0 in Q1 2026, from -$371000.0 in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $773000.0 in Q3 2024 to a low of -$532000.0 in Q3 2023.
• A 5-year average of $114166.7 and a median of $78000.0 in 2022 frame the typical range for Other financing activities.
• Peak annual rise in Other financing activities reached 330.3% in 2023, while the deepest fall reached 2000.0% in 2023.
• Tracing CATX's Other financing activities over 5 years: stood at $30000.0 in 2022, then tumbled by 1873.33% to -$532000.0 in 2023, then soared by 167.11% to $357000.0 in 2024, then tumbled by 203.92% to -$371000.0 in 2025, then surged by 178.17% to $290000.0 in 2026.
• Business Quant data shows CATX's Other financing activities at $290000.0 in Q1 2026, -$371000.0 in Q4 2025, and $371000.0 in Q3 2025.